title: [Prospective study of the causes for destruction of labile blood products during 1999 at a University Hospital Center].
abstract: The destruction of the blood cell product (BCP) is a situation which is hard to accept in the present context of transfusional safety which aims at covering the transfusional needs in the most appropriate way. In our University Hospital, 500 BCP out of 20,000 are destroyed per year, which represent a cost of 100,000 $. A prospective research was carried out from January 1st to December 31st 1999 in order to analyse the causes of the destruction of the BCP and to differentiate the inevitable destructions for the patient's security from the avoidable destructions which might have benefited from corrective measures. For each group of simultaneously destroyed BCP, an information note specified the patient's pathology, the reasons for the prescription, the number and the type of transfused and destroyed BCP in the same day, the time spent between distribution and return, and the causes of destruction. In 1999, a total of 483 LBP out of 19,802 which were distributed, have been returned and destroyed, that is to say 2.4% for a 99.3% traceability which involved 242 patients. Among these destroyed BCP, 28.3% came from inevitable causes--death or acute intensive care which needed a lot of transfusions--69.7% were categorised as being related to avoidable causes depending on the organisation of transport and care, unadapted safety measures. The corrective measures to be taken, concern the improvement of transport procedures, the set-up of a nominative BCP reservation system in the Blood Center, the scheduling of the BCP deliveries from the blood bank, and a better adaptation of the safety measures to the transfusional needs.
authors.affiliation: Pavilion le Blaye, CHU de Poitiers, 350, avenue Jacques-Coeur, 86021 Poitiers, France. e.benz-lemoine@chu-poitiers.fr
authors.forename: E
authors.initials: E
authors.lastname: Benz-Lemoine
authors.forename: B
authors.initials: B
authors.lastname: Baloge
authors.forename: M
authors.initials: M
authors.lastname: Dupuis
authors.forename: X
authors.initials: X
authors.lastname: Champagne
authors.forename: F
authors.initials: F
authors.lastname: Pradeau
authors.forename: J C
authors.initials: JC
authors.lastname: Redersdorff
mesh_terms: D001771:Blood Banks / Q000458:organization & administration / Q000706:statistics & numerical data*; D001793:Blood Preservation / Q000706:statistics & numerical data; D001803:Blood Transfusion / Q000706:statistics & numerical data; D001804:Blood Transfusion, Autologous / Q000706:statistics & numerical data; D003953:Diagnosis-Related Groups; D017707:Erythrocyte Transfusion / Q000706:statistics & numerical data; D005568:Forms and Records Control; D005602:France; D006785:Hospitals, University / Q000458:organization & administration / Q000706:statistics & numerical data*; D006801:Humans; D008485:Medical Audit; D017744:Medical Waste Disposal / Q000706:statistics & numerical data*; D010949:Plasma; D017713:Platelet Transfusion / Q000706:statistics & numerical data; D011446:Prospective Studies; D012449:Safety; D014186:Transportation
chemical_list: D017744:Medical Waste Disposal